首页> 外国专利> Glyco-Metal-Organic Frameworks-based Hepatic Targeted Therapeutic Drug and Preparation Method Thereof

Glyco-Metal-Organic Frameworks-based Hepatic Targeted Therapeutic Drug and Preparation Method Thereof

机译:基于Glyco-金属 - 有机框架的肝脏靶向治疗药物及其制备方法

摘要

The disclosure discloses a glyco-metal-organic frameworks-based hepatic targeted therapeutic drug and a preparation method thereof, and belongs to the field of biomedicine. The disclosure loads a chemotherapeutic drug onto specific metal-organic frameworks, and modifies targeted molecule galactose on the surface of the materials through amide reaction. The biocompatibility and cytotoxicity of the obtained hepatic targeted therapeutic drug have been carefully evaluated at the cellular level. The hepatic targeted therapeutic drug of the disclosure has good stability and acidic pH triggered drug release property, and can exert the synergistic therapeutic effect of photodynamic therapy and chemotherapy. In addition, in vivo behavioral tracing and therapeutic efficacy are evaluated in mouse models with subcutaneous solid tumor and tumor in situ, and the disclosure is expected to play a huge role in clinical applications.
机译:本公开公开了一种基于甘油 - 金属 - 有机框架的肝靶向治疗药物及其制备方法,属于生物医学的领域。 本公开将化学治疗药物载入特定的金属 - 有机骨架上,并通过酰胺反应改变材料表面上的靶向分子半乳糖。 已经在细胞水平上仔细评估了所得肝脏靶向治疗药物的生物相容性和细胞毒性。 本公开的肝脏靶向治疗药具有良好的稳定性和酸性pH引发的药物释放性能,并且可以施加光动力治疗和化疗的协同治疗效果。 此外,在具有皮下固体瘤和肿瘤的小鼠模型中评价体内行为跟踪和治疗效果,原位在小鼠模型中评价,并且预计本公开将在临床应用中发挥巨大作用。

著录项

  • 公开/公告号US2021308280A1

    专利类型

  • 公开/公告日2021-10-07

    原文格式PDF

  • 申请/专利权人 JIANGNAN UNIVERSITY;

    申请/专利号US202117345582

  • 发明设计人 JING HU;JIAN YIN;JUN HU;

    申请日2021-06-11

  • 分类号A61K47/69;A61K31/704;A61K31/44;A61K31/513;A61K41;A61K47/54;A61K47/60;

  • 国家 US

  • 入库时间 2022-08-24 21:30:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号